Conceptio › Archive › ClinicalTrials.gov
ClinicalTrials.govpublic full text

Safety and Efficacy of Lebrikizumab (LY3650150) in Combination With Topical Corticosteroid in Moderate-to-Severe Atopic Dermatitis.

Eli Lilly and Company · 2020
ClinicalTrials.gov · Datasets · License: Public Domain · 2020
Open Source ↗
atopicdermatitisdermatitis
atopic dermatitis, eczema, dermatitis, dermatitis, atopic, skin diseases, interventional, phase3
This document is indexed with metadata only — full text is not available in the archive for this record. Open the official source ↗

Related documents

Record · ID 966997
Retrieved via Conceptio — every document is proof-bundled with source, license, and retrieval metadata.